The relevance of herbal treatments for psychiatric practice

Australian and New Zealand Journal of Psychiatry

Volumn 33, Issue 4, 1999, Pages 482-489

  Walter, Garry ^a   Rey, Joseph M ^a  

^a Rivendell Child & Adolescent Unit   (Australia)

Author keywords

Alternative medicine; Gingko biloba; Herbal treatments; Psychiatry; St John's Wort; Valeriana officinalis

Indexed keywords

HERBACEOUS AGENT; VALERIAN;

ALTERNATIVE MEDICINE; ARTICLE; DEVELOPING COUNTRY; DRUG EFFICACY; DRUG SAFETY; GINKGO BILOBA; HERBAL MEDICINE; HYPERICUM PERFORATUM; MENTAL DISEASE; NOMENCLATURE; PSYCHIATRY;

ADVERSE DRUG REACTION REPORTING SYSTEMS; AUSTRALIA; EDUCATION, MEDICAL, CONTINUING; HUMANS; MENTAL DISORDERS; PATIENT CARE TEAM; PHYSICIAN'S ROLE; PHYTOTHERAPY; PSYCHIATRY;

EID: 0032764807     PISSN: 00048674     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1614.1999.00568.x     Document Type: Article

References (64)

1. Parliament of Victoria Social Development Committee. Inquiry into alternative medicine and the health food industry. Melbourne: Victorian Government Printer, 1986.
2. MacLennan AH, Wilson DH, Taylor AW. Prevalence and cost of alternative medicine in Australia. Lancet 1996; 347:569-573.
3. Kristoffersen SS, Atkiin PA, Shenfield GM. Uptake of alternative medicine. Lancet 1996; 347:972.
4. BMJ News. Complementary medicine is booming worldwide. British Medical Journal 1996; 313:131-133.
5. Eisenberg DM, Davis RB, Ettner SL et al. Trends in alternative medicine use in the United States, 1990-1997: Results of a follow-up national survey. Journal of the American Medical Association 1998; 280:1569-1575.
6. Grunwald J. The European phytomedicines: market figures, trends, analyses. Herbalgram 1995; 34:60-65.
7. De Smet PAG, Nolen WA. St John's Wort as an antidepressant. British Medical Journal 1996; 313:241-242.
8. Jorm AF, Korten AE, Jacomb PA, Christensen H, Rodgers B, Pollitt P. Mental health literacy: A4 survey of the public's ability to recognise mental disorders and their beliefs about the effectiveness of treatment. Medical Journal of Australia 1997; 166:182-186.
9. Cooper J. Complementary medicine discussion group. British Journal of Psychiatry 1998; 173:187.
10. Wong AHC, Smith M, Boon HS. Herbal remedies in psychiatric practice. Archives of General Psychiatry 1998; 55:1033-1044.
11. Brown L, ed. The Oxford Dictionary. Oxford: Oxford University Press. 1995.
12. Gray MA. Herbs: multicultural folk medicines. Othopaedic Nursing 1996; 15:49-56.
13. Weiss RF. Herbal medicine. Beaconsfield, UK: Beaconsfield, 1991.
14. Phillipson JD, Anderson LA. Ethnopharmacology and western medicine. Journal of Ethnopharmacology 1989; 25:61-72.
15. Tyler V. What pharmacists should know about herbal remedies. Journal of the American Pharmaceutical Association 1996; 36:29-37.
16. Houghton PJ. The role of plants in traditional medicine and current therapy. Journal of Alternative and Complementary Medicine 1995; 1:131-143.
17. Rey JM, Walter G. Hypericum perforatum (St John's Wort) in depression: pest or blessing? Medical Journal of Australia 1998; 169:583-586.
18. Mills S. The essential book of herbal medicine. London: Penguin, 1991.
19. Cribb AB, Cribb JW. Wild medicine in Australia. Sydney: Fontana, 1981.
20. Pearn J. The enchanted herb: the work of early medical botanists in Australia. Medical Journal of Australia 1987; 147:568-572.
21. Mills S. The complete guide to modern herbalism. London: Thorsons, 1994.
22. Frawley D. Herbs and the mind. In: Tirra M, ed. American herbalism: essays on herbs and herbalism by members of the American Herbalist Guild. Freedom: Crossing, 1992.
23. Hoffman D. The new holistic herbal. Rockport: Element. 1992.
24. Wilson LG. Cross-cultural differences in indicators of improvement from psychosis. Journal of Nervous and Mental Disease 1979; 167:250-251.
25. Liang-dong Z, Yu-hua T, Wei-bing Z, Shen-han X. Comparative study of schizophrenia treatment with electroacupuncture, herbs and chlorpromazine. Chinese Medical Journal 1987; 100:152-157.
26. Rasmussen P. Phytomedicines for depressive illness: more than just Hypericum. Paper presented at the National Herbalists' Association of Australia International Conference, 13 March 1998, Sydney, Australia.
27. Chen HC, Hsieh MT, Lai E. Studies on suanzaorentang in the treatment of anxiety. Psychopharmacology 1985; 85:486-487.
28. Nebelkopf E. Herbal therapy in the treatment of drug use. International Journal of the Addictions 1987; 22:695-717.
29. Winston D. Attention deficit hyperactivity disorder. Protocol Journal of Botanical Medicine 1996; 2:38-39.
30. Skolnick AA. Old Chinese herbal medicine used for fever yields possible new Alzheimer disease therapy. Journal of the American Medical Association 1997; 277:776.
31. Le Bars PL, Katz MM, Berman M, Itil TM, Freedman MD, Schatzberg AF. A placebo-controlled, double-blind, randomized trial of an extract of Gingko biloba for dementia. Journal of the American Medical Association 1997; 278:1327-1332.
32. Tyler VE. Herbs of choice: the therapeutic use of phytomedicinals. New York: Haworth, 1994.
33. Sato Y, Horita H, Adachi H et al. Effect of oral administration of prostaglandin E1 on erectile dysfunction. British Journal of Urology 1997; 80:772-775.
34. Corrigan D. Herbal medicine for sleep and relaxation. London: Amberwood, 1996.
35. Yamada K. Effectiveness of herbal medicine (shakuyaku-kanzo-to) for neuroleptic-induced hyperprolactinaemia. Journal of Clinical Psychiatry 1997; 17:234-235.
36. Crow TJ, Deakin JFW. Neurohumoral transmission, behaviour and mental disorder. In: Shepherd M, ed. Handbook of psychiatry. Vol. 5. Cambridge: Cambridge University Press, 1985:137-182.
37. Healy D, Savage M. Reserpine exhumed. British Journal of Psychiatry 1998; 172:376-378.
38. Sargant W, Slater E. An introduction to physical methods of treatment in psychiatry. Edinburgh: Churchill Livingstone, 1972.
39. Voth EA, Schwanz RH. Medical applications of delta-9-tetrahydrocannabinol and marijuana. Annals of Internal Medicine 1997; 126:791-798.
40. Morris K. The cannabis remedy: wonder worker or evil weed? Lancet 1828; 1997:350.
41. Newall CA, Anderson LA, Phillipson JD. Herbal medicines: a guide for health care professionals. London: Pharmaceutical, 1996.
42. Bradley PR, ed. British herbal compendium. Bournemouth: British Herbal Medicine Association, 1996.
43. Nash M. Nature's Prozac? Time 1997; 22:80-81.
44. Linde K, Ramirez G, Mulrow CD, Pauls A, Weidenhammer W, Melchart D. St. John's Wort for depression: an overview and meta-analysis of randomized clinical trials. British Medical Journal 1996; 313:253-258.
45. Parsons WT. Noxious weeds of Victoria. Melbourne: Inkata, 1973.
46. Woelk H. Benefits and risks of the hypericum extract L1 160: drug monitoring study with 3250 patients. Journal of Geriatric Psychiatry and Neurology 1994; 7(Suppl. 1):34-38.
47. Thiele B, Brink I, Ploch M. Modulation of cytokine expression by Hypericum extract. Journal of Geriatric Psychiatry and Neurology 1994; 7(Suppl. 1):60-62.
48. Tyler VE. The honest herbal. New York: Pharmaceutical Products, 1993.
49. Cott J. Natural product formulations available in Europe for psychotropic indications. Psychopharmacology Bulletin 1995; 31:745-751.
50. Leathwood PD, Chauffard F. Aqueous extract of valerian reduces latency to fall asleep in man. Planta Medica 1985; 51:144-148.
51. Balderer G, Borbely AA. Effect of valerian on human sleep. Psychopharmacology 1985; 87:406-409.
52. Leathwood PD, Chauffard F. Quantifying the effects of mild sedatives. Journal of Psychiatric Research 1983; 17:115-122.
53. Kohnen R, Oswald WD. The effects of valerian, propanolol, and their combination on activation, performance, and mood of healthy volunteers under social stress conditions. Pharmacopsychiatry 1988; 21:447-448.
54. Holzl J, Godau P. Receptor binding studies with Valeriana officinalis on the benzodiazepine receptor. Planta Medica 1989; 55:642.
55. Riedel E, Hansel R, Ehrke G. Inhibition of GABA catabolism by valerenic acid derivatives. Planta Medica 1982; 46:219-220.
56. Josefson D. Herbal stimulant causes US deaths. British Medical Journal 1996; 312:1441.
57. Doyle H, Kargin M. Herbal stimulant containing ephedrine has also caused psychosis. British Medical Journal 1996; 313:756.
58. Woolf GM, Rojter SE, Villamil FG, Vierling JM. Jin bu hua toxicity in adults. Morbidity and Mortality Weekly Reports 1993; 42:920-922.
59. Vale S. Subarachnoid haemorrhage associated with Gingko biloba. Lancet 1998; 352:36.
60. Shaw D, Leon C, Kolev S, Murray V. Traditional remedies and food supplements: a 5-year toxicological study (1991-1995). Drug Safety 1997; 17:342-356.
61. Drew AK, Myers SP. Safety issues in herbal medicine: implications for the health professions. Medical Journal of Australia 1997; 166:538-541.
62. Akerele O. WHO guidelines for the assessment of herbal medicines. Fitoterapia 1992; 62:99-110.
63. Moulds RFW, McNeil JJ. Herbal preparations: to regulate or not to regulate? Medical Journal of Australia 1988; 149:572-574.
64. Houghton PJ. St John's Wort for depression. British Medical Journal 1996; 313:1204-1205.